← Back to Search

Procedure

Pulsatile blood flow for Acute Kidney Injury

N/A
Waitlist Available
Led By Nathan J Clendenen, MD, MS
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from intensive care unit admission after surgery to hospital discharge, up to 30 days
Awards & highlights

Study Summary

This trial aims to see if using a specific type of blood flow during heart surgery can help reduce the risk of kidney damage. Researchers will also look at how safe and effective this method is compared to the

Who is the study for?
This trial is for patients undergoing cardiac surgery who will be on cardiopulmonary bypass. It's not clear what specific conditions or characteristics make someone eligible or ineligible to participate.Check my eligibility
What is being tested?
The study is testing if pulsatile blood flow (mimicking natural heartbeat rhythms) during cardiopulmonary bypass can reduce kidney damage after heart surgery, compared to non-pulsatile flow (steady stream).See study design
What are the potential side effects?
Potential side effects are not specified, but may include complications related to changes in blood flow during surgery such as increased risk of bleeding, clotting issues, or other impacts on organ function.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from intensive care unit admission after surgery to hospital discharge, up to 30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and from intensive care unit admission after surgery to hospital discharge, up to 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acute kidney injury
Secondary outcome measures
30-day mortality
Acute kidney injury risk score
Discontinuation rate of cardiopulmonary bypass mode
+2 more
Other outcome measures
Duration of mechanical ventilation
Intra-operative cryoprecipitate transfusion in units
Intra-operative plasma transfusion in units
+18 more

Trial Design

2Treatment groups
Active Control
Group I: Pulsatile blood flowActive Control1 Intervention
Pulsatile blood flow during cardiopulmonary bypass
Group II: Non-pulsatile blood flowActive Control1 Intervention
Non-pulsatile blood flow during cardiopulmonary bypass

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,739 Previous Clinical Trials
2,149,045 Total Patients Enrolled
7 Trials studying Acute Kidney Injury
439 Patients Enrolled for Acute Kidney Injury
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,841 Previous Clinical Trials
47,813,005 Total Patients Enrolled
9 Trials studying Acute Kidney Injury
3,446 Patients Enrolled for Acute Kidney Injury
Nathan J Clendenen, MD, MSPrincipal InvestigatorUniversity of Colorado, Denver
1 Previous Clinical Trials
66 Total Patients Enrolled
1 Trials studying Acute Kidney Injury
66 Patients Enrolled for Acute Kidney Injury

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do individuals aged 55 and above meet the criteria for participation in this medical study?

"Enrollment for this research study is open to individuals over 18 years old and under the age of 85."

Answered by AI

Are there any available openings for patients to participate in this medical study?

"Per the details on clinicaltrials.gov, this specific study is not presently accepting applicants. It was initially listed on 4/1/2024 and last revised on 4/4/2024. Despite its current inactivity, it's worth noting that there are currently 1302 other trials actively seeking participants."

Answered by AI
~733 spots leftby Apr 2028